Evidence map›Paper›PMID 24560804›Full record

ArticleStructure (London, England : 1993)2014

Nitric oxide-induced conformational changes in soluble guanylate cyclase.

Eric S Underbakke, Anthony T Iavarone, Michael J Chalmers, Bruce D Pascal, Scott Novick, Patrick R Griffin, Michael A Marletta

Open access · bronzeAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 75 citations in OpenAlex.

  1. Biomolecular NMR assignments · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Boldine, an Alkaloid fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Redox regulation of soluble guanylyl cyclase.Nitric oxide : biology and chemistry · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eric S UnderbakkeDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Anthony T IavaroneDepartment of Chemistry and California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, CA 94720, USA.
Michael J ChalmersDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458, USA.
Bruce D PascalDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458, USA.
Scott NovickDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458, USA.
Patrick R GriffinDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458, USA.
Michael A MarlettaDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: marletta@scripps.edu.
Scripps Research Institute · USQB3 · US

Funding

Acquisition of a LTQ/Orbitrap MS to advance the study of protein dynamicsS10RR027270 · NCRR · SCRIPPS RESEARCH INSTITUTE, THE · PI GRIFFIN, PATRICK ROBERT · 2010 to 2010
$500k
QTOF MASS SPECTROMETER: CELL MOLECULAR BIOLOGY, PROTEIN STRUCTURES10RR022393 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI WILLIAMS, EVAN R · 2006 to 2006
$499k
Mapping The Domain Architecture And Conformations of Soluble Guanylate CyclaseF32GM093564 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI UNDERBAKKE, ERIC STEVEN · 2010 to 2012
$126k
NCRR NIH HHS 1S10RR022393-01NCRR NIH HHS S10 RR022393NCRR NIH HHS S10 RR027270NIGMS NIH HHS 5F32GM093564NIGMS NIH HHS F32 GM093564
6 · The paper itself

Abstract

Soluble guanylate cyclase (sGC) is the primary mediator of nitric oxide (NO) signaling. NO binds the sGC heme cofactor stimulating synthesis of the second messenger cyclic-GMP (cGMP). As the central hub of NO/cGMP signaling pathways, sGC is important in diverse physiological processes such as vasodilation and neurotransmission. Nevertheless, the mechanisms underlying NO-induced cyclase activation in sGC remain unclear. Here, hydrogen/deuterium exchange mass spectrometry (HDX-MS) was employed to probe the NO-induced conformational changes of sGC. HDX-MS revealed NO-induced effects in several discrete regions. NO binding to the heme-NO/O2-binding (H-NOX) domain perturbs a signaling surface implicated in Per/Arnt/Sim (PAS) domain interactions. Furthermore, NO elicits striking conformational changes in the junction between the PAS and helical domains that propagate as perturbations throughout the adjoining helices. Ultimately, NO binding stimulates the catalytic domain by contracting the active site pocket. Together, these conformational changes delineate an allosteric pathway linking NO binding to activation of the catalytic domain.

Indexed as

Amino Acid SequenceCatalytic DomainCyclic GMPEscherichia coliGene ExpressionGuanylate CyclaseHumansModels, MolecularMolecular Sequence DataNitric OxideProtein BindingProtein FoldingProtein MultimerizationProtein Structure, SecondaryProtein SubunitsReceptors, Cytoplasmic and NuclearCyclic GMPGuanylate CyclaseNitric OxideProtein SubunitsReceptors, Cytoplasmic and NuclearRecombinant ProteinsSoluble Guanylyl Cyclase

Identifiers

PMID24560804
PMCPMC4001857
OpenAlexW1995446205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.